Circulating Tumor DNA Testing Supports Rapid Therapeutic Decision-Making in Metastatic Melanoma: A Case Report

Circulating Tumor DNA Testing Supports Rapid Therapeutic Decision-Making in Metastatic Melanoma: A Case Report

Treatment of metastatic melanoma includes the option of targeted therapy in patients with driver BRAF mutations. BRAF-MEK inhibitor drugs improve survival in the approximately 50% of patients with melanoma that harbor BRAF mutations. As BRAF mutation detection in tissue often takes days to weeks, it...

Full description

Bibliographic Details
Main Authors: Tapas Ranjan Behera, Jung Min Song, Jennifer Ko, Donald Eicher, Joshua Arbesman, Brian Gastman, Daniel H. Farkas, Pauline Funchain
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
Rapid ctDNA test
ctDNA
BRAF mutation
rt-PCR
targeted therapy
melanoma
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.846187/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.846187/full

Similar Items